Synthetic and Herbal Oil-Based Topical Creams for Antifungal Therapy: A Comprehensive Review

Abstract

Superficial fungal infections remain a major global public-health burden, driven by high prevalence,
recurrence, and rising resistance to standard agents. This comprehensive review examines contemporary
topical antifungal creams that combine synthetic drugs (azoles, allylamines, polyenes) with herbal oil-based
excipients and actives (for example, neem, tea tree oil, coconut oil, silymarin). We synthesize evidence
from in-vitro studies, formulation research, clinical trials, and quality-control reports to compare antifungal
efficacy, mechanisms of action, skin-penetration strategies, and safety profiles. The review highlights how
herbal oils can serve dual roles as bioactive adjuncts providing intrinsic antifungal, anti-inflammatory, or
wound-healing effects and as formulation vehicles that modify solubility, enhance dermal delivery, and
reduce irritation. We discuss formulation challenges including batch variability of botanical extracts,
compatibility with synthetic actives, stability, and regulatory considerations for hybrid products. Emerging
technologies such as lipid-based nanocarriers, microemulsions, and penetration enhancers are evaluated
for their potential to improve therapeutic outcomes and reduce dosing frequency. Finally, we identify gaps
in the literature notably limited large-scale randomized trials on combination formulations and inconsistent
standardization of herbal constituents and recommend priorities for future research, including standardized
phytochemical profiling, head-to-head clinical comparisons, and safety monitoring frameworks. This review
aims to inform formulators, clinicians, and regulatory stakeholders about the opportunities and limitations
of synthetic–herbal topical antifungal therapies.